COMMUNIQUÉS West-GlobeNewswire

Resignation of Directors

30/01/2018 - 11:00

MELBOURNE, Australia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq: GENE ) (“Company”), advises that Dr Malcolm R. Brandon and Mr Grahame Leonard, AM have resigned as directors of the [...]

Helsinn Healthcare S.A.: Helsinn and the Scientific Centre of Monaco Sign Collaboration Agreement

30/01/2018 - 10:00

Helsinn and the Scientific Centre of Monaco Sign Collaboration Agreement Investigating the role of pharmacological inhibitors in kidney cancer Lugano, Switzerland, January 30, 2018 - Helsinn International Services, Sarl [...]

FIRE1 Raises EUR 40 Million in Series C Financing

30/01/2018 - 08:00

DUBLIN, Ireland, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Foundry Innovation & Research 1, Ltd. (FIRE1), today announced the close of a Series C financing totaling EUR 40 Million. The financing was led by new investor [...]

Cannabis Wheaton Income Corp. Announces Expansion to Uruguay and Securing of Significant CBD-Rich Hemp Production

30/01/2018 - 07:55

VANCOUVER, British Columbia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or "Wheaton" or the " Company ") is pleased to announce that it has [...]

Innate Pharma and MedImmune enter clinical trial collaboration

30/01/2018 - 07:01

Innate Pharma and MEDIMMUnE Enter clinical trial collaboration Innate Pharma and MedImmune will evaluate the combination of Innate Pharma's first-in-class IPH5401 antibody and Imfinzi ® (durvalumab) in a Phase I/II [...]

Innate Pharma et MedImmune démarrent une collaboration clinique

30/01/2018 - 07:01

Innate Pharma et MEDIMMUNE démarrent une collaboration clinique Innate Pharma et MedImmune vont évaluer la combinaison d'IPH5401, l'anticorps « first-in-class » d'Innate Pharma, et d' Imfinzi ® (durvalumab) dans une [...]

Alder BioPharmaceuticals, Inc. Announces Pricing of $250 Million of 2.50% Convertible Senior Notes Due 2025

30/01/2018 - 04:25

BOTHELL, Wash., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, announced [...]

Cannabis Wheaton Income Corp. Announces Completion of Previously Announced Debt Settlement

30/01/2018 - 02:09

VANCOUVER, British Columbia, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Cannabis Wheaton " or the " Company ") has completed the shares for debt settlement with [...]

CymaBay Announces Proposed Public Offering of Common Stock

29/01/2018 - 22:44

NEWARK, Calif., Jan. 29, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Auris Medical Announces Pricing of $5.5 Million Registered Direct Offering

29/01/2018 - 22:31

Zug, Switzerland, January 29, 2018 - Auris Medical Holding AG ("Auris Medical", NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, [...]

Surgery Partners Announces Executive Leadership Transitions

29/01/2018 - 22:30

David Kretschmer appointed Chief Strategy and Transformation Officer; Executive with more than 35 years of financial and corporate strategy experience Mr. Kretschmer to serve as interim Chief Financial Officer, [...]

Vestaron Corporation is Named in the 2018 Global Cleantech 100

29/01/2018 - 22:29

KALAMAZOO, Mich., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Vestaron Corporation, a leading developer of peptide-based bioinsecticides, today announced it was named in the prestigious 2018 Global Cleantech 100 , produced by CTG [...]

Five Prime Therapeutics Announces Closing of Upsized Public Offering

29/01/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq: FPRX ) announced today the closing of its upsized public offering of 5,897,435 shares of its common stock, which [...]

Eyenovia Announces Closing of $27.3 Million Initial Public Offering

29/01/2018 - 22:05

NEW YORK, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”), (NASDAQ: EYEN ), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print [...]

Amarin Announces Proposed Public Offering of American Depositary Shares

29/01/2018 - 22:01

BEDMINSTER, N.J., and DUBLIN, Ireland, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ) today announced a registered underwritten public offering of its American Depositary Shares. All of the [...]

Albireo Announces Closing of $74.8 Million Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares

29/01/2018 - 22:01

BOSTON, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the completion of its [...]

Iovance Biotherapeutics, Inc. Announces Closing of $172.5 Million Common Stock Public Offering

29/01/2018 - 22:01

SAN CARLOS, Calif., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]

Diffusion Pharmaceuticals Announces First Patient Dosed in Phase 3 Trial with TSC in Inoperable Glioblastoma Multiforme

29/01/2018 - 22:00

CHARLOTTESVILLE, Va., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN ) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]

Misonix to Report Fiscal 2018 Second Quarter Financial Results, Host Conference Call and Webcast on February 6

29/01/2018 - 19:40

FARMINGDALE, N.Y., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON ) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]